IPF: Dr. Martina Vašáková on Overcoming Barriers to Diagnosis

IPF-related Decline in Lung Function May Be Evident Within 6 Months

A new study reported that patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) often experience lung function decline, which furthers disease progression. The study, titled “Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis,” was published in the journal…

IPF Patients and Doctors on Lookout for New Treatment Approaches

Spherix Global Insights, GmbH, a business intelligence and market research company based on Switzerland, recently reported a study revealing that idiopathic pulmonary fibrosis (IPF) remains a challenge in terms of treatment, especially since the majority of patients are diagnosed at already advanced disease stages. The Spherix study is entitled “…

Read the Top 10 Pulmonary Fibrosis Articles of 2015

10. “Esbriet’s Promise and Potential as a PF Therapy” Read full article here: https://bit.ly/1HX2qZt Read Top 10 Pulmonary Fibrosis Articles of 2015: https://bit.ly/1OuOHvG 9. “Tissue Engineering Grows New Lungs in Lab That Could Revolutionize IPF Treatment” Read full article here: https://bit.ly/1RPnfcB Read Top…